Inhibrx Biosciences (INBX) Interest & Investment Income (2023 - 2025)
Historic Interest & Investment Income for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $1.8 million.
- Inhibrx Biosciences' Interest & Investment Income fell 3834.72% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 3956.58%. This contributed to the annual value of $10.9 million for FY2024, which is 819.84% down from last year.
- As of Q3 2025, Inhibrx Biosciences' Interest & Investment Income stood at $1.8 million, which was down 3834.72% from $2.1 million recorded in Q2 2025.
- Over the past 5 years, Inhibrx Biosciences' Interest & Investment Income peaked at $4.7 million during Q4 2023, and registered a low of $1.8 million during Q3 2025.
- Moreover, its 3-year median value for Interest & Investment Income was $2.4 million (2023), whereas its average is $2.7 million.
- Examining YoY changes over the last 5 years, Inhibrx Biosciences' Interest & Investment Income showed a top increase of 2444.06% in 2024 and a maximum decrease of 5734.67% in 2024.
- Inhibrx Biosciences' Interest & Investment Income (Quarter) stood at $4.7 million in 2023, then plummeted by 57.35% to $2.0 million in 2024, then dropped by 10.98% to $1.8 million in 2025.
- Its Interest & Investment Income stands at $1.8 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.3 million for Q1 2025.